Profile data is unavailable for this security.
About the company
Combigene AB is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company specializes in development of treatments for neurological disorders. The Company's platform comprises the use of gene therapy vectors delivering a combination of transgenes encoding two or more of neuropeptide Y (NPY) receptors, galanin, galanin receptors, somatostatin, and somatostatin receptors, for the treatment of neurological and psychiatric diseases in humans and animals. The Company focuses on the development of an epilepsy treatment by means of an adeno-associated virus (AAV) vector carrying the transgenes for the neurotransmitter NPY and one of its receptors, the G protein-coupled receptor Y2.
- Revenue in SEK (TTM)1.91m
- Net income in SEK-36.52m
- Incorporated1990
- Employees10.00
- LocationCombigene ABAgavagen 52ALIDINGOE 181 55SwedenSWE
- Phone+46 406718906
- Websitehttps://combigene.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stayble Therapeutics AB | 0.00 | -20.40m | 28.64m | 2.00 | -- | 2.34 | -- | -- | -0.6413 | -0.6413 | 0.00 | 0.2795 | 0.00 | -- | -- | 0.00 | -81.91 | -78.64 | -93.24 | -95.58 | -- | -- | -- | -- | -- | -- | 0.065 | -- | -- | -- | 3.22 | -- | -- | -- |
| SoftOx Solutions AS | 1.61m | -58.81m | 33.34m | 7.00 | -- | 0.2297 | -- | 20.69 | -0.7729 | -0.7729 | 0.0022 | 0.0766 | 0.0166 | -- | 0.493 | 237,141.40 | -60.65 | -50.11 | -81.43 | -63.61 | -- | -- | -3,649.40 | -639.34 | 0.4049 | -2.76 | 0.1463 | -- | -1.88 | 10.06 | 44.55 | -- | 39.43 | -- |
| Scandion Oncology A/S | 0.00 | -54.53m | 33.86m | 4.00 | -- | 0.725 | -- | -- | -0.3727 | -0.3727 | 0.00 | 0.2014 | 0.00 | -- | -- | 0.00 | -72.35 | -- | -84.88 | -- | -- | -- | -- | -- | -- | -- | 0.0058 | -- | -- | -- | 48.89 | -- | -- | -- |
| ATTANA AB | 5.14m | -12.18m | 35.31m | 10.00 | -- | 2.18 | -- | 6.87 | -0.0361 | -0.0361 | 0.0148 | 0.0376 | 0.1715 | -0.4127 | 1.97 | 514,073.00 | -40.63 | -37.18 | -62.57 | -46.66 | 127.26 | 175.97 | -236.92 | -254.69 | 0.4858 | -4.43 | 0.158 | -- | -32.89 | 6.61 | 5.80 | -- | 8.21 | -- |
| Peptonic Medical AB | 39.05m | -45.25m | 35.68m | 37.00 | -- | 0.1917 | -- | 0.9138 | -0.025 | -0.025 | 0.0222 | 0.0323 | 0.4185 | 1.42 | 5.49 | 1,055,432.00 | -48.49 | -46.02 | -61.53 | -60.85 | 44.34 | 54.26 | -115.88 | -139.38 | 0.5002 | -140.41 | 0.2084 | -- | -14.93 | 149.65 | -15.55 | -- | 27.15 | -- |
| Fluicell AB | 1.30m | -27.16m | 37.36m | 11.00 | -- | 1.73 | -- | 28.81 | -0.1493 | -0.1493 | 0.0055 | 0.045 | 0.0525 | 0.5265 | 1.98 | 76,294.12 | -109.94 | -87.55 | -141.87 | -126.02 | -17.66 | 72.97 | -2,094.37 | -650.23 | 3.83 | -695.51 | 0.00 | -- | 2.68 | 22.18 | -22.90 | -- | -- | -- |
| Double Bond Phrmcutcl Intrntnl AB (publ) | 1.20m | -16.75m | 37.57m | 10.00 | -- | 10.10 | -- | 31.30 | -0.18 | -0.18 | 0.0125 | 0.0351 | 0.0949 | -- | 21.10 | 120,004.00 | -132.48 | -80.90 | -176.94 | -106.45 | -344.65 | -1,073.66 | -1,395.47 | -1,360.03 | 1.12 | -1.36 | 0.00 | -- | 10.25 | 135.07 | -14.36 | -- | -- | -- |
| Respiratorius AB (publ) | 1.35m | -7.30m | 37.63m | -- | -- | 0.9465 | -- | 27.94 | -0.0229 | -0.0229 | 0.0042 | 0.078 | 0.0461 | -- | -- | -- | -24.98 | -- | -26.52 | -- | 63.66 | -- | -542.36 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -9.55 | -- |
| Orphazyme A/S | 0.00 | -17.38m | 47.69m | 1.00 | -- | 1.95 | -- | -- | -325.75 | -325.75 | 0.00 | 455.65 | 0.00 | -- | -- | 0.00 | -42.26 | -76.08 | -50.77 | -105.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.00 | -- | -- | -- |
| Combigene AB | 1.91m | -36.52m | 49.90m | 10.00 | -- | 0.5269 | -- | 26.07 | -1.84 | -1.84 | 0.0967 | 4.78 | 0.0161 | -- | 3.71 | 239,265.00 | -30.66 | -13.00 | -32.33 | -14.58 | -- | -- | -1,908.16 | -58.77 | -- | -- | 0.00 | -- | -79.23 | 268.58 | -479.27 | -- | -24.02 | -- |
| Nidhogg Resources Holding AB (publ) | 32.00k | -4.21m | 54.09m | 3.00 | -- | 59.38 | -- | 1,690.42 | -0.0021 | -0.0021 | 0.00005 | 0.0005 | 0.0087 | -- | 0.0128 | 10,666.67 | -114.92 | -70.56 | -204.32 | -82.81 | -25,093.75 | -- | -13,156.25 | -- | -- | -- | -- | -- | -- | -- | 77.06 | -- | -- | -- |
| ViroGates A/S | 8.08m | -20.00m | 56.94m | 10.00 | -- | 4.01 | -- | 7.05 | -5.78 | -5.78 | 1.18 | 1.45 | 0.3331 | 0.3869 | 6.80 | 530,700.00 | -82.42 | -46.58 | -89.49 | -52.09 | 69.49 | 77.91 | -247.47 | -238.01 | 8.60 | -19.26 | 0.3626 | -- | -45.01 | 10.98 | -25.40 | -- | -- | -- |
| Modus Therapeutics Holding AB | 0.00 | -15.01m | 59.84m | 2.00 | -- | 6.08 | -- | -- | -0.5898 | -0.5898 | 0.00 | 0.2738 | 0.00 | -- | -- | 0.00 | -165.57 | -141.06 | -- | -278.44 | -- | -- | -- | -- | -- | -18.39 | 0.00 | -- | -- | -- | 2.31 | -- | -- | -- |
| Ultimovacs ASA | 0.00 | -174.02m | 61.19m | 23.00 | -- | 0.2899 | -- | -- | -5.21 | -5.21 | 0.00 | 6.32 | 0.00 | -- | -- | 0.00 | -51.97 | -28.80 | -57.15 | -31.12 | -- | -- | -- | -- | -- | -114.19 | 0.0137 | -- | -- | -- | -12.78 | -- | -45.35 | -- |
| Abera Bioscience AB | 0.00 | -7.63m | 62.48m | 6.00 | -- | 7.10 | -- | -- | -0.5213 | -0.5213 | 0.00 | 0.5733 | 0.00 | -- | -- | 0.00 | -73.37 | -79.42 | -98.59 | -96.10 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 13.74 | -- | -- | -- |
| PCI Biotech Holding ASA | 5.82m | -15.53m | 64.79m | 7.00 | -- | 2.09 | -- | 11.13 | -0.4287 | -0.4287 | 0.1607 | 0.8548 | 0.1334 | -- | 0.9365 | 857,000.00 | -35.59 | -36.44 | -40.42 | -40.14 | -- | -- | -266.74 | -1,055.43 | -- | -- | 0.0147 | -- | -37.05 | -20.78 | 63.13 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Combigene AB's reporting currency: Swedish Krona SEK
0.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FCG Fonder ABas of 30 Aug 2024 | 1.80k | 0.01% |
Data from 30 Aug 2024 - 30 Aug 2024Source: FactSet Research Systems Inc.
